Steward Partners Investment Advisory’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $327K | Sell |
2,552
-58
| -2% | -$7.43K | ﹤0.01% | 1516 |
|
|
2025
Q1 | $231K | Hold |
2,610
| – | – | ﹤0.01% | 1576 |
|
|
2024
Q4 | $228K | Sell |
2,610
-741
| -22% | -$64.6K | ﹤0.01% | 1531 |
|
|
2024
Q3 | $310K | Buy |
3,351
+741
| +28% | +$68.5K | ﹤0.01% | 1320 |
|
|
2024
Q2 | $281K | Buy |
2,610
+476
| +22% | +$51.3K | ﹤0.01% | 1302 |
|
|
2024
Q1 | $202K | Sell |
2,134
-5,475
| -72% | -$519K | ﹤0.01% | 1428 |
|
|
2023
Q4 | $702K | Sell |
7,609
-3,075
| -29% | -$284K | 0.01% | 850 |
|
|
2023
Q3 | $537K | Buy |
10,684
+8,227
| +335% | +$413K | 0.01% | 899 |
|
|
2023
Q2 | $155K | Buy |
2,457
+775
| +46% | +$49K | ﹤0.01% | 1384 |
|
|
2023
Q1 | $75.7K | Buy |
1,682
+335
| +25% | +$15.1K | ﹤0.01% | 1699 |
|
|
2022
Q4 | $59K | Sell |
1,347
-197
| -13% | -$8.63K | ﹤0.01% | 1771 |
|
|
2022
Q3 | $102K | Buy |
1,544
+227
| +17% | +$15K | ﹤0.01% | 1490 |
|
|
2022
Q2 | $67K | Buy |
1,317
+700
| +113% | +$35.6K | ﹤0.01% | 1659 |
|
|
2022
Q1 | $39K | Buy |
617
+497
| +414% | +$31.4K | ﹤0.01% | 2042 |
|
|
2021
Q4 | $13K | Hold |
120
| – | – | ﹤0.01% | 2490 |
|
|
2021
Q3 | $12K | Sell |
120
-1,091
| -90% | -$109K | ﹤0.01% | 2529 |
|
|
2021
Q2 | $107K | Sell |
1,211
-374
| -24% | -$33K | ﹤0.01% | 2151 |
|
|
2021
Q1 | $154K | Buy |
1,585
+1,050
| +196% | +$102K | ﹤0.01% | 1411 |
|
|
2020
Q4 | $60K | Sell |
535
-45
| -8% | -$5.05K | ﹤0.01% | 1581 |
|
|
2020
Q3 | $54K | Buy |
580
+345
| +147% | +$32.1K | ﹤0.01% | 1467 |
|
|
2020
Q2 | $18K | Sell |
235
-240
| -51% | -$18.4K | ﹤0.01% | 1806 |
|
|
2020
Q1 | $27K | Sell |
475
-310
| -39% | -$17.6K | ﹤0.01% | 1489 |
|
|
2019
Q4 | $62K | Buy |
+785
| New | +$62K | ﹤0.01% | 1310 |
|